Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173532 | 1.00 | PTPN1 (0.38) | PTPN1G6PC1HSD11B1MEP1BMEN1 | |
| SCHEMBL1173533 | 1.00 | PTPN1 (0.38) | PTPN1G6PC1HSD11B1MEP1BMEN1 | |
| SCHEMBL1173760 | 0.79 | KDM4E (0.37) | OPRM1OPRD1ALDH1A1 | |
| SCHEMBL1173757 | 0.79 | KDM4E (0.37) | OPRM1OPRD1ALDH1A1 | |
| SCHEMBL1173759 | 0.79 | KDM4E (0.37) | OPRM1OPRD1ALDH1A1 | |
| SCHEMBL8983573 | 0.75 | G6PC1 (0.47) | PTPN1G6PC1MEN1KMT2ACNR2 | |
| SCHEMBL8983564 | 0.75 | G6PC1 (0.47) | PTPN1G6PC1MEN1KMT2ACNR2 | |
| SCHEMBL8983569 | 0.75 | G6PC1 (0.47) | PTPN1G6PC1MEN1KMT2ACNR2 | |
| SCHEMBL14905722 | 0.73 | AOC3 (0.40) | MEN1KMT2AALDH1A1TSHR | |
| SCHEMBL12411286 | 0.71 | ALDH1A1 (0.45) | G6PC1CNR2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436173-B2 | Boron compounds, their production processes, and functional electronic devices using same | KYOTO UNIVERSITY (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20110046372-A1 | NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME | Kyoto University and Nippon Shokubai Co., LTD. | 2011-02-24 | — | — | US | disclosed |
| EP-2233490-A1 | NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME | Kyoto University (JP) | 2010-09-29 | — | — | EP | disclosed |
| EP-2233490-A1 | NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME | Kyoto University (JP) | 2010-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046372-A1 | NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME | ETFB, SLC40A1, SLC19A1 | PTPN1 2579/4885G6PC1 2243/4885HSD11B1 3133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.